EA201300393A1 - ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS) - Google Patents
ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS)Info
- Publication number
- EA201300393A1 EA201300393A1 EA201300393A EA201300393A EA201300393A1 EA 201300393 A1 EA201300393 A1 EA 201300393A1 EA 201300393 A EA201300393 A EA 201300393A EA 201300393 A EA201300393 A EA 201300393A EA 201300393 A1 EA201300393 A1 EA 201300393A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- pharmaceutical composition
- options
- therapeutic effect
- antioxidant
- antioxidant pharmaceutical
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Изобретение относится к области фармацевтической промышленности, медицине. Задачей настоящего изобретения является создание эффективного антиоксидантного фармацевтического состава. Задача решается за счет того, что антиоксидантный фармацевтический состав, содержащий метилэтилпиридинола гидрохлорид, дополнительно содержит минеральные вещества: натрий, калий, кальций, железо, магний, цинк, а также содержит изотопы углеродаС и изотопы азотаN. Изобретение описано в четырех вариантах реализации. Техническими результатами изобретения являются увеличение срока годности фармацевтического состава; увеличение лечебного эффекта, а также скорости наступления лечебного эффекта.The invention relates to the field of pharmaceutical industry, medicine. The present invention is the creation of an effective antioxidant pharmaceutical composition. The problem is solved due to the fact that the antioxidant pharmaceutical composition containing methyl ethyl pyridinol hydrochloride additionally contains minerals: sodium, potassium, calcium, iron, magnesium, zinc, and also contains carbon isotopes and nitrogen isotopesN. The invention is described in four embodiments. The technical results of the invention are to increase the shelf life of the pharmaceutical composition; increase therapeutic effect, as well as the rate of onset of therapeutic effect.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EA201300393A EA201300393A1 (en) | 2013-04-22 | 2013-04-22 | ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS) |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EA201300393A EA201300393A1 (en) | 2013-04-22 | 2013-04-22 | ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS) |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201300393A1 true EA201300393A1 (en) | 2014-10-30 |
Family
ID=51794634
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201300393A EA201300393A1 (en) | 2013-04-22 | 2013-04-22 | ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS) |
Country Status (1)
Country | Link |
---|---|
EA (1) | EA201300393A1 (en) |
-
2013
- 2013-04-22 EA EA201300393A patent/EA201300393A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JO3438B1 (en) | Aryl- or heteroaryl-substituted benzene compounds | |
EA201592200A1 (en) | DERIVATIVES OF SULFAMOILPYRROLAMIDE AND THEIR APPLICATION AS MEDICINES FOR THE TREATMENT OF HEPATITIS B | |
EA201591591A1 (en) | COMPOUNDS OF CARBAZOLE APPLIED AS Bromodomain Inhibitors | |
EA201391285A1 (en) | Derivatives of tetrahydroquinoline, useful as bromodomain inhibitors | |
NZ720651A (en) | Fused heterocyclic compounds as ion channel modulators | |
EA201692481A1 (en) | COMBINATION CONTAINING GLUCOCORTICOID AND EDO-S101 | |
EA201300393A1 (en) | ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS) | |
EA201300376A1 (en) | ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS) | |
EA201300394A1 (en) | ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS) | |
EA201300378A1 (en) | ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS) | |
EA201300371A1 (en) | ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS) | |
EA201300372A1 (en) | ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS) | |
EA201300392A1 (en) | ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS) | |
EA201300377A1 (en) | ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS) | |
EA201300373A1 (en) | ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS) | |
EA201300370A1 (en) | ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS) | |
EA201200359A1 (en) | PHARMACEUTICAL COMPOSITION, HAVING A NEUROPROTECTIVE, ANTI-AMNESTIC, ANTIOXIDANT, ANTIPIOPOXIC, NEUROMETABOLIC, ANTIVYCHEMICAL ACTIVITY (OPTIONS) | |
EA201200343A1 (en) | PHARMACEUTICAL COMPOSITION, HAVING A NEUROPROTECTIVE, ANTI-AMNESTIC, ANTIOXIDANT, ANTIPIOPOXIC, NEUROMETABOLIC, ANTIVYCHEMICAL ACTIVITY (OPTIONS) | |
EA201200858A1 (en) | PHARMACEUTICAL COMPOSITION, HAVING METABOLIC, ANTI-PATH, RETINOPROTECTIVE ACTION (OPTIONS) | |
EA201200315A1 (en) | PHARMACEUTICAL COMPOSITION, HAVING A NEUROPROTECTIVE, ANTI-AMNESTIC, ANTIOXIDANT, ANTIPIOPOXIC, NEUROMETABOLIC, ANTIVYCHEMICAL ACTIVITY (OPTIONS) | |
EA201201220A1 (en) | PHARMACEUTICAL COMPOSITION, HAVING METABOLIC, ANTI-PATH, RETINOPROTECTIVE ACTION (OPTIONS) | |
EA201201217A1 (en) | PHARMACEUTICAL COMPOSITION, HAVING METABOLIC, ANTI-PATH, RETINOPROTECTIVE ACTION (OPTIONS) | |
EA201201216A1 (en) | PHARMACEUTICAL COMPOSITION, HAVING METABOLIC, ANTI-PATH, RETINOPROTECTIVE ACTION (OPTIONS) | |
EA201201215A1 (en) | PHARMACEUTICAL COMPOSITION, HAVING METABOLIC, ANTI-PATH, RETINOPROTECTIVE ACTION (OPTIONS) | |
EA201201212A1 (en) | PHARMACEUTICAL COMPOSITION, HAVING METABOLIC, ANTI-PATH, RETINOPROTECTIVE ACTION (OPTIONS) |